Journals / Sakarya Tıp Dergisi / 2018 / Cilt: 8 - Sayı: 2

Hidden Blood Loss, Infection and Cost-Effectiveness of Tranexamic Acid Protocol in Primary Total Knee Arthroplasty

Primer Total Diz Artroplastisi İçin Traneksamik Asid Kullanımında Gizli Kan Kaybı, Enfeksiyon ve Fiyat-Fayda Oranı

Pages
423–431
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No complication such as infection or thromboemboli was detected among the study groups.Conclusion Combined topical and continuous up to 24 hours intravenous administration of TXA reduced the total blood loss and decreased drainagevolume, as well as reducing hidden blood loss.Level of evidence III.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose was to evaluate the effect of combined administration of TXA on total blood loss, hidden blood loss, drain output, costeffectiveness and periprosthetic infection rate in patients undergoing unilateral primary knee arthroplasty.Sakarya Med J, 2018, 8(2):423-431 )Materials andMethodsWe enrolled fi fty-eight patients with primary gonarthrosis undergoing unilateral primary knee arthroplasty between May 2014 andDecember 2014.
📊
Key Findings & Data:We compared 29 cases performed without the application of TXA to 29 cases performed with the application of TXA.Our TXA protocol consisted of three stages.Results Postoperative hemoglobin and hematocrit levels were found to be signifi cantly lower in the non-TXA group.
💡
Conclusion & Impact:No complication such as infection or thromboemboli was detected among the study groups.Conclusion Combined topical and continuous up to 24 hours intravenous administration of TXA reduced the total blood loss and decreased drainagevolume, as well as reducing hidden blood loss.Level of evidence III.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The purpose was to evaluate the effect of combined administration of TXA on total blood loss, hidden blood loss, drain output, costeffectiveness and periprosthetic infection rate in patients undergoing unilateral primary knee arthroplasty.Sakarya Med J, 2018, 8(2):423-431 )Materials andMethodsWe enrolled fi fty-eight patients with primary gonarthrosis undergoing unilateral primary knee arthroplasty between May 2014 andDecember 2014. We compared 29 cases performed without the application of TXA to 29 cases performed with the application of TXA.Our TXA protocol consisted of three stages.Results Postoperative hemoglobin and hematocrit levels were found to be signifi cantly lower in the non-TXA group. Estimated blood loss, hiddenblood loss, and drain output were found to be higher in the non-TXA group. Transfusion rate was lower in TXA group. The blood bankcosts were found to be higher in the non-TXA group. The total direct cost was also higher in the non-TXA group. This was average 29.9$savings per case in the TXA group. No complication such as infection or thromboemboli was detected among the study groups.Conclusion Combined topical and continuous up to 24 hours intravenous administration of TXA reduced the total blood loss and decreased drainagevolume, as well as reducing hidden blood loss.Level of evidence III.

Özet

Amaç Tek tarafl ı primer total diz artroplastisi uygulanan hastalarda kombine traneksamik asid (TXA) kullanımının total kan kaybı, gizli kan kaybı, drenaj miktarı, kost efektivite ve periprostetik enfeksiyon oranı üzerine etkisini değerlendirmektir. ( Sakarya Tıp Dergisi, 2018, 8(2):423-431 ). Gereç ve Yöntem 2014 yılı Mayıs ve Aralık ayları arasında primer gonartroz tanısı ile tek tarafl ı primer total diz artroplastisi uygulanmış olan 58 hasta çalışmaya dahil edilmiştir. TXA uygulanmamış 29 hasta ile TXA uygulanmış olan 29 hasta karşılaştırılmıştır. Söz konusu TXA protokolü 3 aşamadan oluşmaktadır. Bulgular Ameliyat sonrası hemoglobin ve hematokrit seviyeleri non-TXA grubunda anlamlı olarak düşük bulundu. Gene tahmini kan kaybı, gizli kan kaybı ve drenden olan kayıp miktarı non-TXA grubunda daha yüksek bulundu. Transfüzyon oranı TXA grubunda daha düşüktü. Kan bankası masrafl arı non-TXA grubunda daha yüksek bulundu. Total masrafl ar da gene non-TXA grubunda daha yüksek idi. TXA grubunda vaka başına 29,9 USD daha az masraf söz konusu idi. Çalışma gruplarında enfeksiyon veya tromboemboli gibi komplikasyonlara rastlanmadı. Sonuç Topikal ve 24 saat sürekli intravenöz TXA’in kombine kullanımı total kan kaybı, drenaj hacminin yanı sıra gizli kan kaybı miktarını da azaltır. Kanıt düzeyi III

🔖

Cite This Article

SEZGİN, H., GÜÇLÜ, B., BASAT, H. Ç., KÖKER, Y., BOZDUMAN, Ö., KIRÇIL, C. (2022). Hidden Blood Loss, Infection and Cost-Effectiveness of Tranexamic Acid Protocol in Primary Total Knee Arthroplasty. Sakarya Tıp Dergisi, Cilt: 8 - Sayı: 2, 423–431. https://ajindex.com/articles/590458

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Good L, Peterson E and Lisander B. Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br J Anaesth 2003; 90: 596-599. 2003/04/17
  2. Lotke PA, Faralli VJ, Orenstein EM, et al. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Joint Surg Am 1991; 73: 1037-1040. 1991/08/01
  3. Sehat KR, Evans R and Newman JH. How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee 2000; 7: 151-155. 2000/08/06
  4. Lee SH, Cho KY, Khurana S, et al. Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 2013; 21: 2611-2617. 2012/10/12. DOI: 10.1007/s00167-012-2213-1
  5. Georgiadis AG, Muh SJ, Silverton CD, et al. A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013; 28: 78-82. 2013/08/03. DOI: 10.1016/j. arth.2013.03.038
  6. Zhao-Yu C, Yan G, Wei C, et al. Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. Knee Surg Sports Traumatol Arthrosc 2014; 22: 3181- 3190. 2013/12/20. DOI: 10.1007/s00167-013-2814-3
  7. Imai N, Dohmae Y, Suda K, et al. Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 2012; 27: 1838-1843. 2012/06/19. DOI: 10.1016/j.arth.2012.04.024
  8. Astedt B. Clinical pharmacology of tranexamic acid. Scand J Gastroenterol Suppl 1987; 137: 22-25. 1987/01/01
  9. Schulman S. Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program 2012; 2012: 517-521. 2012/12/13. DOI: 10.1182/asheducation-2012.1.517
  10. Alshryda S, Sarda P, Sukeik M, et al. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93: 1577-1585. 2011/12/14. DOI: 10.1302/0301-620X.93B12.26989
  11. Gandhi R, Evans HM, Mahomed SR, et al. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184. 2013/05/09. DOI: 10.1186/1756-0500- 6-184
  12. Huang F, Wu D, Ma G, et al. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res 2014; 186: 318-327. 2013/10/01. DOI: